Neuraxis Inc. (NYSE AMERICAN: NRXS) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT NEURAXIS INC.

Neuraxis Inc. (NYSE AMERICAN: NRXS)
Listen to this Section


$7.23
+0.1550 ( +2.19% ) 68.4K

Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).

Market Data


Open $7.23
Previous Close $7.07
Volume 68.4K
Market Cap $87.56M
Day Range $6.92 - $7.25
52 Week Range $2.20 - $9.33
Shares Outstanding 12.38M
Change % +2.19%
Net Change ▲ 0.1550
Insider Ownership N/A
Exchange NYSE AMERICAN
SectorHealthcare
Industry
IPO Year2023
Country
UnderwriterAlexander Capital, more

Insider Ownership Transactions

Total Amount Purchased: -465,335.00

Date Type Amount Purchased Purchaser
2025-07-03 Buy 355556.00 Hannasch Brian
2024-07-02 Sale -11580.00 Watkins Bradley Mitchell
2024-07-02 Sale -11580.00 Keyser Jane Elizabeth
2024-07-02 Sale -1183.00 Ferge Kristin A
2024-02-29 Sale -75000.00 Hannasch Brian
2024-02-14 Sale -150000.00 Hannasch Brian
2024-01-23 Sale -40000.00 Hannasch Brian
2023-08-10 Sale -531548.00 MASIMO CORP

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 81 Nov 10, 2025
8-k 8K-related 14 Oct 24, 2025
8-k 8K-related 12 Oct 23, 2025
4 Insider transactions 1 Sep 10, 2025
4 Insider transactions 1 Sep 10, 2025
4 Insider transactions 1 Sep 10, 2025
4 Insider transactions 1 Sep 10, 2025
4 Insider transactions 1 Sep 10, 2025
4 Insider transactions 1 Sep 10, 2025
4 Insider transactions 1 Sep 10, 2025

Latest News


× Before browsing our site, please accept our cookies policy